AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

PERTUZUMAB

10 registrations across 8 African markets— 8 active

Markets with PERTUZUMAB

🇿🇼Zimbabwe
3 registrations
3 active
🇬🇭Ghana
1 registration
0 active
🇰🇪Kenya
1 registration
1 active
🇳🇬Nigeria
1 registration
1 active
🇨🇮Côte d'Ivoire
1 registration
1 active
🇿🇦South Africa
1 registration
1 active
🇿🇲Zambia
1 registration
1 active
🇹🇳Tunisia
1 registration
0 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
FYCOMPA 6MG
TABLET, COATED; ORAL
🇿🇼ZimbabweEISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,activeApr 2031
FYCOMPA 8MG
TABLET, COATED; ORAL
🇿🇼ZimbabweEISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,activeApr 2031
Pertjeta
Solution for influsion
🇿🇲ZambiaRoche ProductsactiveMay 2030
PERJETA🇿🇦South AfricaRoche Products (Pty) LtdactiveNov 2029
Perjeta 420 mg Concentrate for Solution for Infusion**
Concentrate for solution for infusion
🇳🇬NigeriaRoche Products LimitedactiveJun 2029
Perjeta 420mg
Concentrate For Solution For Infusion
🇰🇪KenyaF. Hoffman-la Roche Ltd, BaselactiveApr 2028
PERJETA
SOLUTION; INJECTION
🇿🇼ZimbabweROCHE PRODUCTS (PTY) LTDactiveDec 2027
PERJETA 420MG/14 ML SOLUTION INJECTABLE FLACON DE 14ML🇨🇮Côte d'IvoireF. HOFFMANN-LA ROCHE LTDactiveMay 2027
PERJETA🇬🇭Ghana—expiredJun 2026
PERJETA
Solution injectable pour perfusion / 420 mg
🇹🇳TunisiaRoche Pharma (Schweiz) AGexpiredApr 2019

PERTUZUMAB in Africa — Regulatory Overview

PERTUZUMAB is registered across 8 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Ghana, Kenya, Nigeria and 4 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 8 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.